NO20013933L - peptides - Google Patents

peptides

Info

Publication number
NO20013933L
NO20013933L NO20013933A NO20013933A NO20013933L NO 20013933 L NO20013933 L NO 20013933L NO 20013933 A NO20013933 A NO 20013933A NO 20013933 A NO20013933 A NO 20013933A NO 20013933 L NO20013933 L NO 20013933L
Authority
NO
Norway
Prior art keywords
peptides
trp
naturally occurring
expression methods
occurring type
Prior art date
Application number
NO20013933A
Other languages
Norwegian (no)
Other versions
NO20013933D0 (en
Inventor
Nicholas Mazarakis
Enca Martin-Rendon
Susan Kingsman
Original Assignee
Oxford Biomedica Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford Biomedica Ltd filed Critical Oxford Biomedica Ltd
Publication of NO20013933D0 publication Critical patent/NO20013933D0/en
Publication of NO20013933L publication Critical patent/NO20013933L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Abstract

Et ikke-naturlig forekommende Type I Repeat Peptide (TRP) og ekspresjonsmetoder derav.A non-naturally occurring Type I Repeat Peptide (TRP) and its expression methods.

NO20013933A 1999-02-15 2001-08-13 peptides NO20013933L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9903408.4A GB9903408D0 (en) 1999-02-15 1999-02-15 Peptides
PCT/GB2000/000520 WO2000047622A2 (en) 1999-02-15 2000-02-15 Peptides with anti-angiogenic activity

Publications (2)

Publication Number Publication Date
NO20013933D0 NO20013933D0 (en) 2001-08-13
NO20013933L true NO20013933L (en) 2001-10-15

Family

ID=10847793

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20013933A NO20013933L (en) 1999-02-15 2001-08-13 peptides

Country Status (10)

Country Link
EP (1) EP1161454A2 (en)
JP (1) JP2002542762A (en)
KR (1) KR20010092800A (en)
CN (1) CN1340059A (en)
AU (1) AU2559600A (en)
CA (1) CA2359750A1 (en)
GB (2) GB9903408D0 (en)
IL (1) IL144376A0 (en)
NO (1) NO20013933L (en)
WO (1) WO2000047622A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7696307B2 (en) * 2004-04-12 2010-04-13 The Trustees Of The University Of Pennsylvania Function and regulation of ADAMTS-1
CA2688145C (en) * 2007-06-19 2016-10-04 Emory University A method of treating abnormal angiogenesis via the bai family of proteins and their protein fragments
EP2340034B2 (en) * 2008-08-07 2019-02-13 The United States Of America, As Represented By The Secretary, Department of Health and Human Services Radioprotectants targeting thrombospondin-1 and cd47
CN110227159B (en) * 2018-03-05 2021-09-21 义慧科技(深圳)有限公司 Medicine for improving drug resistance of solid tumor to anti-vascular drugs and application of CPT1a inhibitor in medicine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5491130A (en) * 1992-11-10 1996-02-13 The United States Of America As Represented By The Department Of Health And Human Services Peptide inhibitors of fibronectin and related collagen-binding proteins
WO1996037621A2 (en) * 1995-05-23 1996-11-28 Morphosys Gesellschaft Für Proteinoptimierung Mbh Multimeric proteins

Also Published As

Publication number Publication date
NO20013933D0 (en) 2001-08-13
WO2000047622A3 (en) 2001-01-11
JP2002542762A (en) 2002-12-17
GB0120713D0 (en) 2001-10-17
WO2000047622A2 (en) 2000-08-17
AU2559600A (en) 2000-08-29
CN1340059A (en) 2002-03-13
IL144376A0 (en) 2002-05-23
CA2359750A1 (en) 2000-08-17
GB2362887A (en) 2001-12-05
EP1161454A2 (en) 2001-12-12
KR20010092800A (en) 2001-10-27
GB9903408D0 (en) 1999-04-07

Similar Documents

Publication Publication Date Title
ATE264863T1 (en) 28-EPIRAPALOGUE
DK0881906T4 (en) Pharmaceutical composition for immunomodulation based on peptides and adjuvants
NO992492D0 (en) Benzamidoaldehydes and their use as cysteine protease inhibitors
ES2110386T1 (en) INTERFERON CONJUGATES.
ATE259352T1 (en) CYSTEINE PROTEASE INHIBITORS
DK0965578T3 (en) Hitherto unknown triglycerics and preparations which comprise this
NO995891D0 (en) LH-RH peptide analogues, uses and pharmaceutical compositions containing them
NO975966L (en) Procedure for parallel chain decoding and decoding, and associated circuits
EP1304791A4 (en) Source voltage conversion circuit and its control method, display, and portable terminal
ATE241997T1 (en) NON-AQUEOUS PROTIC PEPTIDE PREPARATIONS
NO982918D0 (en) Procedure, system and switches for channelized telecommunications service
DK1259547T3 (en) HIGH POTENTIAL, RECOMBINANT ANTIBODIES AND PROCEDURE FOR PRODUCING THEM
NO2008012I2 (en) Dabigatran ethoxylate and its salts - especially dabigatran ethoxylate mesylate
WO2001077951A8 (en) System and methods for group retirement plan administration
ATE321786T1 (en) PEPTIDE WITH RADIOPROTECTIVE EFFECT
IS6181A (en) Single and double accessible 3-propyl-gamma amino butyric acids
ES2191830T3 (en) THROMBIN INHIBITORS.
AU4966101A (en) Methods of making and using 7alpha,11beta-dimethyl-17beta-hydroxy-4-estren-3-one17beta-trans-4-m-butylcyclohexane carboxylate and 7alpha,11beta-dimethyl-17beta -hydroxyestr-4-en-3-one 17-undecanoate
NO20031860D0 (en) Kahalaolid F
NO20013853D0 (en) Heteroberlamidines, methylamidines and guanidines as protease inhibitors
NO20013933L (en) peptides
NO20040880L (en) Casein-derived peptides and applications thereof in therapy.
NO20043145L (en) Base station and mobile communication system using this
IL139604A (en) Fibrinogen-beta chain derived peptide, compositions comprising same and use thereof
NO20005547D0 (en) Myelin-based protein peptides and uses thereof

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application